Binghamton University Enters Research Agreement with Sunshine Biopharma
Sunshine Biopharma and Binghamton University have entered into a research and development agreement to conduct clinical studies and Phase 1 trials on a new drug to treat breast and prostate cancer.
The drug inhibits an enzyme found in drug resistant forms of breast cancer as... Read More.













